Cancer patient gets pig liver transplant
HEFEI — Chinese researchers have successfully transplanted a genetically modified pig liver into a human patient with severe liver cancer, they announced on Friday, marking a breakthrough in xenotransplantation involving humans.
The First Affiliated Hospital of Anhui Medical University in Hefei, the capital of Anhui province, said the operation was conducted on May 17 by a team led by Professor Sun Beicheng from the hospital, in collaboration with a team led by Professor Wei Hong jiang from Yunnan Agricultural University.
Sun said that the 71-year-old patient's body did not reject the organ within the first seven days following the operation, nor did he experience any disorder to his coagulation system.
The operation was the first clinically assisted pig-to-human xenogenic liver transplant and the fifth xenogeneic organ transplant in the world, he said.
The patient is able to move around freely, and his liver function and many other health indicators have returned to normal, Sun said.
Last month, Chinese researchers successfully transplanted a genetically modified pig liver into a brain-dead patient at Xijing Hospital at Air Force Medical University in Xi'an, capital of Shaanxi province.
Xinhua
- 150-million-year-old fossil sheds light on bird tail evolution
- Air China adds direct Beijing-Venice link
- China warming faster than global average as extreme weather intensifies, report says
- Xinjiang cotton demonstrates vitality, resilience
- Pearl, Yangtze river basins face heightened flood risks in July
- China launches 100-day recruitment campaign for college graduates































